These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 19684604)
1. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604 [TBL] [Abstract][Full Text] [Related]
2. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence. Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773 [TBL] [Abstract][Full Text] [Related]
3. Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India. Bhandari P; Ahmad F; Mandava S; Das BR Asian Pac J Cancer Prev; 2016; 17(8):3989-95. PubMed ID: 27644650 [TBL] [Abstract][Full Text] [Related]
4. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Prasad RB; Hosking FJ; Vijayakrishnan J; Papaemmanuil E; Koehler R; Greaves M; Sheridan E; Gast A; Kinsey SE; Lightfoot T; Roman E; Taylor M; Pritchard-Jones K; Stanulla M; Schrappe M; Bartram CR; Houlston RS; Kumar R; Hemminki K Blood; 2010 Mar; 115(9):1765-7. PubMed ID: 20042726 [TBL] [Abstract][Full Text] [Related]
5. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Pastorczak A; Górniak P; Sherborne A; Hosking F; Trelińska J; Lejman M; Szczepański T; Borowiec M; Fendler W; Kowalczyk J; Houlston RS; Młynarski W Leuk Res; 2011 Nov; 35(11):1534-6. PubMed ID: 21889209 [TBL] [Abstract][Full Text] [Related]
6. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population. Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142 [TBL] [Abstract][Full Text] [Related]
7. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children. Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407 [TBL] [Abstract][Full Text] [Related]
8. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan. Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646 [TBL] [Abstract][Full Text] [Related]
9. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population. Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171 [TBL] [Abstract][Full Text] [Related]
10. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Vijayakrishnan J; Sherborne AL; Sawangpanich R; Hongeng S; Houlston RS; Pakakasama S Leuk Lymphoma; 2010 Oct; 51(10):1870-4. PubMed ID: 20919861 [TBL] [Abstract][Full Text] [Related]
11. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250 [TBL] [Abstract][Full Text] [Related]